Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.06 EUR | +3.46% |
|
+2.10% | +39.87% |
02:32pm | MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms caused by menopause | RE |
02:28pm | UK Clears Bayer Medicine for Menopause-related Hot Flashes | MT |
Official Publications
Threshold crossings | 06-22 | CO |
Threshold crossings | 06-22 | CO |
1st quarter report | 05-12 | CO |
1st quarter report | 05-12 | CO |
Shareholders meeting voting results | 04-24 | CO |
Shareholders meeting voting results | 04-24 | CO |
Annual ESG Report | 03-04 | CO |
Annual Report | 03-04 | CO |
Annual Report | 03-04 | CO |
3rd quarter results | 11-11 | CO |
3rd quarter results | 11-11 | CO |
3rd quarter report | 11-11 | CO |
3rd quarter report | 11-11 | CO |
Half-year report | 05/08/24 | CO |
Half-year report | 05/08/24 | CO |
1st quarter report | 13/05/24 | CO |
1st quarter report | 13/05/24 | CO |
Shareholders meeting voting results | 25/04/24 | CO |
Mixed general shareholder meeting | 10/03/24 | CO |
Annual ESG Report | 04/03/24 | CO |
Annual ESG Report | 04/03/24 | CO |
Annual financial report | 04/03/24 | CO |
Annual financial report | 04/03/24 | CO |
Annual Report | 04/03/24 | CO |
Annual Report | 04/03/24 | CO |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Official Publications
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition